SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-051015
Filing Date
2021-08-12
Accepted
2021-08-12 10:42:04
Documents
1
Period of Report
2021-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6519
  Complete submission text file 0001209191-21-051015.txt   8641
Mailing Address 400 TECH. SQ. 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECH. SQ. 10TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Atlas Venture Associates X, LLC (Reporting) CIK: 0001742765 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 211165987

Mailing Address 400 TECHNOLOGY SQ. 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQ. 10TH FLOOR CAMBRIDGE MA 02139 857-201-2700
ATLAS VENTURE ASSOCIATES X, L.P. (Reporting) CIK: 0001742766 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 211165988

Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)